BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, June 3, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 1, 2012
View Archived Issues
AEOL-10150 demonstrates neuroprotective effects in rat model
Read More
Computational model includes all molecular components and interactions of pathogen's life cycle
Read More
Phase I/II trial assesses ROSE-010 in IBS-C
Read More
Vivalis synthesizes new candidate hepatitis therapies
Read More
New colimycin biosynthesis genes patented
Read More
Zetonna launched in U.S.
Read More
Omeros discovers key proteins in MASP-2 program
Read More
Novel protein kinase inhibitors disclosed by Leo Pharma
Read More
Phase I ALS-2200 data disclosed
Read More
Chinese researchers present new candidate cancer drugs
Read More
Novel tubulin polymerization inhibitors patented by group in Taiwan
Read More
U.S. university patents novel mGlu5 receptor modulators
Read More
Torii Pharmaceutical launches new Mitizax trials in Japan
Read More
La Jolla Pharmaceutical gives update on GCS-100 plans
Read More
Transgene and Tasly Pharmaceutical form joint venture
Read More
APP gene variant linked to reduced cognitive decline
Read More
FDA accepts Zelrix NDA resubmission for filing
Read More
CytoDyn to acquire antibody inhibiting HIV entry
Read More
Oncobiologics to utilize Xoma antibody technology platform
Read More
Second phase of malaria grant awarded to PolyMedix
Read More
MolecularMD seeks approval for companion diagnostic test
Read More
GenSpera's lead product clear to advance to phase II testing
Read More
Clinical proof of concept demonstrated for SCY-635
Read More
Recruitment complete in pivotal CRUISE trials
Read More
EryDel product receives orphan drug status for ataxia telangiectasia
Read More
